AIM: To investigate the influence of Trichuris muris (T. muris) infection in a mouse model of genetic susceptibility to inflammatory bowel disease, Mdr1a-/-. METHODS: Mdr1a-/- mice were housed under specific pathogen free conditions to slow the development of colitis and compared to congenic FVB controls. Mice were infected with approximately 200 embryonated ova from T. muris and assessed for worm burden and histological and functional markers of gut inflammation on day 19 post infection. RESULTS: Mdr1a-/- mice exhibited a marked increase in susceptibility to T. muris infection with a 10-fold increase in colonic worm count by day 19 pi compared to FVB controls. Prior to infection, Mdr1a-/- exhibited low-level mucosal inflammation with evidence of an enhanced Th1 environment. T. muris infection accelerated the progression of colitis in Mdr1a-/- as evidenced by marked increases in several indicators including histological damage score, mucosal CD⁺ T-cell and DC infiltration and dramatically increased production of pro-inflammatory cytokines. CONCLUSION: These data provide further evidence of the complex interaction between T. muris and an inflammatory bowel disease (IBD)-susceptible host which may have relevance to the application of helminth therapy in the treatment of human IBD.
AIM: To investigate the influence of Trichuris muris (T. muris) infection in a mouse model of genetic susceptibility to inflammatory bowel disease, Mdr1a-/-. METHODS:Mdr1a-/- mice were housed under specific pathogen free conditions to slow the development of colitis and compared to congenic FVB controls. Mice were infected with approximately 200 embryonated ova from T. muris and assessed for worm burden and histological and functional markers of gut inflammation on day 19 post infection. RESULTS:Mdr1a-/- mice exhibited a marked increase in susceptibility to T. muris infection with a 10-fold increase in colonic worm count by day 19 pi compared to FVB controls. Prior to infection, Mdr1a-/- exhibited low-level mucosal inflammation with evidence of an enhanced Th1 environment. T. muris infection accelerated the progression of colitis in Mdr1a-/- as evidenced by marked increases in several indicators including histological damage score, mucosal CD⁺ T-cell and DC infiltration and dramatically increased production of pro-inflammatory cytokines. CONCLUSION: These data provide further evidence of the complex interaction between T. muris and an inflammatory bowel disease (IBD)-susceptible host which may have relevance to the application of helminth therapy in the treatment of human IBD.
Authors: Arthur M Blum; Long Hang; Tommy Setiawan; Joseph P Urban; Korynn M Stoyanoff; John Leung; Joel V Weinstock Journal: J Immunol Date: 2012-07-27 Impact factor: 5.422
Authors: W J Sandborn; D E Elliott; J Weinstock; R W Summers; A Landry-Wheeler; N Silver; M D Harnett; S B Hanauer Journal: Aliment Pharmacol Ther Date: 2013-06-03 Impact factor: 8.171
Authors: Mark S Wilson; Thirumalai R Ramalingam; Aymeric Rivollier; Kevin Shenderov; Margaret M Mentink-Kane; Satish K Madala; Allen W Cheever; David Artis; Brian L Kelsall; Thomas A Wynn Journal: Gastroenterology Date: 2010-10-14 Impact factor: 22.682
Authors: Eva Pastille; Annika Frede; Henry J McSorley; Jessica Gräb; Alexandra Adamczyk; Sebastian Kollenda; Wiebke Hansen; Matthias Epple; Jan Buer; Rick M Maizels; Robert Klopfleisch; Astrid M Westendorf Journal: PLoS Pathog Date: 2017-09-22 Impact factor: 6.823
Authors: Yifan Wu; Megan Duffey; Saira Elizabeth Alex; Charlie Suarez-Reyes; Eva H Clark; Jill E Weatherhead Journal: Front Immunol Date: 2022-08-31 Impact factor: 8.786